ArticleClinical cancer research : an official journal of the American Association for Cancer Research2014

Selective JAK2 inhibition specifically decreases Hodgkin lymphoma and mediastinal large B-cell lymphoma growth in vitro and in vivo.

Yansheng Hao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.